Walgreens Boots Alliance Raises Its 2021 Forecast After Reporting an 8.4% Boost in Quarterly Profit

Pictured: tall, glass-covered skyscrapers

Source: Dreamstime

Reading time: 2 minutes

On Wednesday, the U.S.-based holding company reported that it has so far administered 8 million COVID-19 vaccines.

The company’s shares went up 2.6% in premarket trading in response to the upbeat earnings results, as well as due to Walgreens Boots Alliance’s announcement that it will raise its 2021 profit forecast as it now expects mid-to-high single-digit growth.

Here are the main financial highlights from the company’s Q2 earnings report:


– 288.5 million prescriptions filled and earnings per share of $1.40

– Second-quarter revenue rose to $32.8 billion (analysts expected $35.53 billion)

– Net income amounted to $1.0 billion vs. $946 million a year earlier


While the pandemic has no doubt disrupted prescription volumes in the past months, the high demand for COVID-19 tests and vaccines has more than compensated for this, with Walgreens Boots Alliance stating as early as in Q1 that it expects to profit from its vaccination efforts in the second half of 2021.

Upcoming reports

See the full list of upcoming earnings reports for 5 – 9 April in the tables below.

Tuesday, 6th of April 2021

Country of originCompany nameFiscal period
United StatesPaychex Inc
Q3 2021

Thursday, 8th of April 2021

Country of originCompany nameFiscal period
United StatesLevi Strauss & Co
Q1 2021
United StatesConstellation Brands Inc
Q4 2021
GermanyGerresheimer AG
Q1 2021


Looking to trade on the global markets? Open a demo account in Delta Trading and test your strategies in a real market environment, without the risk of losing any real funds.


Posted in Market news and tagged , , , .

Leave a Reply